Heparin/heparan sulphate binding in the TGF-β cytokine superfamily
暂无分享,去创建一个
[1] W. N. Pappano,et al. Cell-surface Heparan Sulfate Proteoglycans Potentiate Chordin Antagonism of Bone Morphogenetic Protein Signaling and Are Necessary for Cellular Uptake of Chordin* , 2004, Journal of Biological Chemistry.
[2] Xinhua Lin,et al. Drosophila Dpp Morphogen Movement Is Independent of Dynamin-Mediated Endocytosis but Regulated by the Glypican Members of Heparan Sulfate Proteoglycans , 2004, Cell.
[3] John A Latham,et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist , 2003, The EMBO journal.
[4] R. Kamijo,et al. Sulfated Polysaccharides Enhance the Biological Activities of Bone Morphogenetic Proteins* , 2003, Journal of Biological Chemistry.
[5] C. Innis,et al. Crystal Structures of the Heparan Sulfate-binding Domain of Follistatin , 2003, Journal of Biological Chemistry.
[6] A. Irie,et al. Heparan sulfate is required for bone morphogenetic protein-7 signaling. , 2003, Biochemical and biophysical research communications.
[7] J. Turnbull,et al. Structural Determinants of Heparan Sulphate Modulation of GDNF Signalling , 2003, Growth factors.
[8] R. Mummery,et al. The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFRalpha1. , 2003, Glycobiology.
[9] C. Rider. Interaction between glial-cell-line-derived neurotrophic factor (GDNF) and 2-O-sulphated heparin-related glycosaminoglycans. , 2003, Biochemical Society transactions.
[10] T. Jardetzky,et al. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.
[11] V. Wilson,et al. Role of heparan sulfate-2-O-sulfotransferase in the mouse. , 2002, Biochimica et biophysica acta.
[12] Markus Affolter,et al. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin , 2002, Nature.
[13] M. Barnett,et al. Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan , 2002, Journal of Cell Science.
[14] Naoto Ueno,et al. Action Range of BMP Is Defined by Its N-Terminal Basic Amino Acid Core , 2002, Current Biology.
[15] A. Economides,et al. Heparan Sulfate Proteoglycans Retain Noggin at the Cell Surface , 2002, The Journal of Biological Chemistry.
[16] M. Affolter,et al. Biochemical and Biophysical Characterization of RefoldedDrosophila DPP, a Homolog of Bone Morphogenetic Proteins 2 and 4* , 1998, The Journal of Biological Chemistry.
[17] R. Beddington,et al. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. , 1998, Genes & development.
[18] M. Lyon,et al. The Interaction of the Transforming Growth Factor-βs with Heparin/Heparan Sulfate Is Isoform-specific* , 1997, The Journal of Biological Chemistry.
[19] M. Grütter,et al. The crystal structure of TGF‐β3 and comparison to TGF‐β2: Implications for receptor binding , 1996, Protein science : a publication of the Protein Society.
[20] W. Sebald,et al. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. , 1996, European journal of biochemistry.
[21] D. L. Griffith,et al. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[22] H. Fox. Growth and degeneration of the pronephric system of Rana temporaria. , 1962, Journal of embryology and experimental morphology.
[23] O. Avsian-Kretchmer,et al. Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. , 2004, Molecular endocrinology.